Spontaneous Regression of Cancer: Revealing Granulocytes and Oxidative Stress as the Crucial Double-edge Sword.

BACKGROUND It is commonly believed that cancer development is irreversible, organ-specific as well as systemic malignant disorder, often associated with harmful oxidative stress and inflammation. However, there are also well-documented cases of spontaneous cancer regression, the causative mechanisms of which are not understood. It is known that inflammation is a negative pathophysiological process that may support the development of cancer, but it is also believed that the immune system as well as oxidative stress play important roles in prevention of cancer development and defense against tumor progression. Hence, in animal models spontaneous regression of cancer could be mediated by rapid inflammatory response of granulocytes, acting against cancer mostly as innate immune response. In addition, the administration of granulocytes at the site of solid tumors can lead to tumor regression or can slow down tumor growth and extend the overall survival of animals. In both cases, similar to the radiotherapy, surgery and various chemotherapies, oxidative stress occurs generating lipid peroxidation product 4-hydroxynonenal (4-HNE). This "second messenger of free radicals" acts as growth regulating signaling molecule that exerts relatively selective cytotoxicity against cancer cells. CONCLUSIONS We hypothesize that abundant inflammation and metabolic changes caused by cancer and oxidative stress producing of 4-HNE may be crucial mechanisms for spontaneous cancer regression.

[1]  L. Milković,et al.  Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response , 2022, Molecules.

[2]  S. Kaliki,et al.  Spontaneous regression of presumed ocular surface squamous neoplasia: A report of 8 cases , 2021, European journal of ophthalmology.

[3]  Mohammed Alsabri,et al.  Resolution of pituitary microadenoma after coronavirus disease 2019: a case report , 2021, Journal of Medical Case Reports.

[4]  S. Patole,et al.  Partial Regression of Congenital Brain Stem Glioma and Its Outcome , 2021, Journal of Pediatric Neurology.

[5]  F. Stafford,et al.  Spontaneous regression of advanced-stage oropharyngeal squamous cell carcinoma , 2021, The Journal of Laryngology & Otology.

[6]  Richard Mitchell,et al.  Spontaneous Regression of Metastatic Lesions of Adenocarcinoma of the Gastro-Esophageal Junction , 2021, Cureus.

[7]  B. Bystricky,et al.  Spontaneous Regression of Merkel Cell Carcinoma: Case Report , 2021, International medical case reports journal.

[8]  T. Buchler,et al.  Spontaneous Regression of Metastatic Renal Cell Carcinoma after SARS-CoV-2 Infection: A Report of Two Cases , 2021, Current oncology.

[9]  Qin Xu,et al.  Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona , 2021, Acta pharmaceutica Sinica. B.

[10]  A. Gourine,et al.  Proteomic Analysis of Cardiac Adaptation to Exercise by High Resolution Mass Spectrometry , 2021, Frontiers in Molecular Biosciences.

[11]  Xueting Cai,et al.  Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Changhwan Kim,et al.  Complete spontaneous remission of small cell lung cancer in the absence of specific treatment: A case report , 2021, Thoracic cancer.

[13]  T. Rodríguez,et al.  DB Special Issue - Cell Competition in Development and Disease. , 2021, Developmental biology.

[14]  Toshihiro Tanaka,et al.  Spontaneous regression of hidroacanthoma simplex after skin biopsy , 2021, Dermatologica Sinica.

[15]  N. Žarković,et al.  Lipid peroxidation in brain tumors , 2021, Neurochemistry International.

[16]  H. Sakura,et al.  Spontaneous Regression of Small Cell Lung Carcinoma and Associated Hemichorea , 2021, Internal medicine.

[17]  I. Bhan,et al.  Spontaneous Immune-Mediated Regression of Hepatocellular Carcinoma With High Tumor Mutational Burden , 2021, JCO precision oncology.

[18]  J. Gil-Albarova,et al.  Spontaneous regression of solitary osteochondromas in children: An option to consider in clinical practice , 2021, Joint diseases and related surgery.

[19]  A. Akarca,et al.  Burkitt lymphoma with a granulomatous reaction: an M1/Th1‐polarised microenvironment is associated with controlled growth and spontaneous regression , 2021, Histopathology.

[20]  Ghazaleh Kheiri,et al.  Spontaneous regression of congenital brain tumors: a report of two cases , 2021, Child's Nervous System.

[21]  E. Lam,et al.  Spontaneous regression of an extragonadal seminomatous germ cell tumor. , 2021, Cancer treatment and research communications.

[22]  N. Jha,et al.  Oxidative Stress in Cancer Cell Metabolism , 2021, Antioxidants.

[23]  Takaaki Ito,et al.  Spontaneous Regression of Malignant Pleural Mesothelioma, Possibly Caused by CD8+ Tumor-infiltrating Lymphocytes , 2021 .

[24]  X. Shen,et al.  Classic Kaposi sarcoma in a patient of Miao ethnicity followed up for 7 years: a case report , 2021, Journal of Medical Case Reports.

[25]  Taku Yasumoto,et al.  Spontaneous regression of lung metastases after transarterial chemoembolization for hepatocellular carcinoma , 2021, Radiology case reports.

[26]  D. Sze,et al.  Spontaneous Regression of Hepatocellular Carcinoma: When the Immune System Stands Up to Cancer , 2021, Hepatology.

[27]  N. Žarković,et al.  Short overview on the relevance of microRNA-reactive oxygen species (ROS) interactions and lipid peroxidation for modulation of oxidative stress-mediated signalling pathways in cancer treatment. , 2021, The Journal of pharmacy and pharmacology.

[28]  Yasuyuki Fujita,et al.  Cell competition-induced apical elimination of transformed cells, EDAC, orchestrates the cellular homeostasis. , 2021, Developmental biology.

[29]  T. Kodera,et al.  Spontaneous Regression of Blastic Plasmacytoid Dendritic Cell Neoplasm Following Sepsis by Serratia marcescens: A Case Report and Literature Review , 2021, Internal medicine.

[30]  S. Sánchez-Ramón,et al.  Complete Spontaneous Regression of Lung Metastases after Resection of CIC-Rearranged Sarcoma: A Case Report , 2021, Case Reports in Oncology.

[31]  Vera C. Martins,et al.  Cell competition in hematopoietic cells: Quality control in homeostasis and its role in leukemia. , 2021, Developmental biology.

[32]  D. Power,et al.  Spontaneous Regression of a Pulmonary Metastasis Secondary to Contralateral Metastasectomy. , 2021, The Annals of thoracic surgery.

[33]  A. C. Gasparovic,et al.  Sensitivity of Osteosarcoma Cells to Concentration-Dependent Bioactivities of Lipid Peroxidation Product 4-Hydroxynonenal Depend on Their Level of Differentiation , 2021, Cells.

[34]  N. Ohike,et al.  Spontaneous regression of gastric gastrinoma after resection of metastases to the lesser omentum: A case report and review of literature , 2021, World journal of gastroenterology.

[35]  A. Charpiot,et al.  Vestibular schwannomas with spontaneous shrinkage: about 35 cases , 2021, European Archives of Oto-Rhino-Laryngology.

[36]  Masayuki Yamamoto,et al.  The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment , 2020, Cancers.

[37]  Y. Akagi,et al.  Spontaneous regression of lung metastases in hepatocellular carcinoma: A case report. , 2020, International journal of surgery case reports.

[38]  A. Rapoport,et al.  Spontaneous regression of adenocarcinoma of submandibular gland , 2020, Brazilian journal of otorhinolaryngology.

[39]  Naveen D. Bhandarkar,et al.  Spontaneous Involution of Juvenile Nasopharyngeal Angiofibromas: Report of a Case , 2020, The Laryngoscope.

[40]  G. De Rosa,et al.  Rare case of uterine cervix lymphoma with spontaneous regression: Case report , 2020, The journal of obstetrics and gynaecology research.

[41]  L. Milković,et al.  The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies , 2020, Antioxidants.

[42]  Nathan D. Cecava,et al.  Desmoid-type fibromatosis of the lower extremity: A unique case of complete lesion resolution following core needle biopsy. , 2020, Clinical imaging.

[43]  T. Matsuda,et al.  Spontaneous Regression of Mismatch Repair-Deficient Colon Cancer: A Case Series. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[44]  M. Loda,et al.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. , 2020, Advanced drug delivery reviews.

[45]  A. Yoshizawa,et al.  Spontaneous regression of mismatch repair‐deficient colorectal cancers: Case series , 2020, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[46]  S. Möller,et al.  An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro , 2020, Frontiers in Immunology.

[47]  N. Žarković,et al.  Utilizing Iron for Targeted Lipid Peroxidation as Anticancer Option of Integrative Biomedicine: A Short Review of Nanosystems Containing Iron , 2020, Antioxidants.

[48]  N. Žarković,et al.  The Appearance of 4-Hydroxy-2-Nonenal (HNE) in Squamous Cell Carcinoma of the Oropharynx , 2020, Molecules.

[49]  Shakeel U. R. Mir,et al.  Scavenging reactive oxygen species selectively inhibits M2 macrophage polarization and their pro-tumorigenic function in part, via Stat3 suppression. , 2019, Free radical biology & medicine.

[50]  L. Milković,et al.  The relevance of pathophysiological alterations in redox signaling of 4-hydroxynonenal for pharmacological therapies of major stress-associated diseases. , 2019, Free radical biology & medicine.

[51]  R. Cavalli,et al.  Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells. , 2019, Free radical biology & medicine.

[52]  N. Žarković,et al.  Altered Lipid Metabolism in Blood Mononuclear Cells of Psoriatic Patients Indicates Differential Changes in Psoriasis Vulgaris and Psoriatic Arthritis , 2019, International journal of molecular sciences.

[53]  D. Jackson,et al.  Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. , 2019, Cancer cell.

[54]  N. Žarković,et al.  The Role of Acrolein and NADPH Oxidase in the Granulocyte-Mediated Growth-Inhibition of Tumor Cells , 2019, Cells.

[55]  S. Lowe,et al.  Tumor Cell‐Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy , 2018, Immunity.

[56]  A. Blendea,et al.  Evaluation of Immunostaining for 4-Hydroxy-2-Nonenal Receptors in Cutaneous Malignant Melanoma Immunohistochemical Study of 55 Cases , 2017 .

[57]  C. Yokoyama,et al.  Induction of oxidative stress by anticancer drugs in the presence and absence of cells. , 2017, Oncology letters.

[58]  L. Milković,et al.  Cancer growth regulation by 4‐hydroxynonenal , 2017, Free radical biology & medicine.

[59]  K. Ramana,et al.  Regulatory roles of glutathione-S-transferases and 4-hydroxynonenal in stress-mediated signaling and toxicity. , 2017, Free radical biology & medicine.

[60]  N. Žarković,et al.  Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases. , 2017, Free radical biology & medicine.

[61]  L. Milković,et al.  Short overview on metabolomics approach to study pathophysiology of oxidative stress in cancer , 2017, Redox biology.

[62]  L. Milković,et al.  Amaranth oil reduces accumulation of 4-hydroxynonenal-histidine adducts in gastric mucosa and improves heart rate variability in duodenal peptic ulcer patients undergoing Helicobacter pylori eradication , 2017, Free radical research.

[63]  Meilan Xue,et al.  Apoptosis is induced by docosahexaenoic acid in breast cancer cells via death receptor and mitochondria-mediated pathways. , 2017, Molecular medicine reports.

[64]  N. Žarković,et al.  Positron emission tomography-computed tomography and 4-hydroxynonenal-histidine immunohistochemistry reveal differential onset of lipid peroxidation in primary lung cancer and in pulmonary metastasis of remote malignancies , 2017, Redox biology.

[65]  P. Mouthuy,et al.  Biocompatibility of implantable materials: An oxidative stress viewpoint. , 2016, Biomaterials.

[66]  O. El-Kabbani,et al.  Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism. , 2016, Chemico-biological interactions.

[67]  N. Žarković,et al.  Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells , 2016, Redox biology.

[68]  V. Víctor,et al.  Role of ROS and RNS Sources in Physiological and Pathological Conditions , 2016, Oxidative medicine and cellular longevity.

[69]  Qiuyan Liu,et al.  Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils , 2016, Journal of immunology research.

[70]  C. McClain,et al.  Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice , 2016, Cellular and molecular gastroenterology and hepatology.

[71]  C. Sohn,et al.  Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration , 2016, Journal of Cancer.

[72]  S. Beloribi-Djefaflia,et al.  Lipid metabolic reprogramming in cancer cells , 2016, Oncogenesis.

[73]  N. Žarković,et al.  The pathophysiology of otosclerosis: Review of current research , 2015, Hearing Research.

[74]  G. Di Trapani,et al.  Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma , 2015, Redox biology.

[75]  L. Milković,et al.  Overview on major lipid peroxidation bioactive factor 4-hydroxynonenal as pluripotent growth-regulating factor , 2015, Free radical research.

[76]  Juan R. Cubillos-Ruiz,et al.  ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis , 2015, Cell.

[77]  G. Bauer,et al.  Revealing mechanisms of selective, concentration-dependent potentials of 4-hydroxy-2-nonenal to induce apoptosis in cancer cells through inactivation of membrane-associated catalase. , 2015, Free radical biology & medicine.

[78]  Yan Liang,et al.  Lipid Peroxidation-Mediated Inflammation Promotes Cell Apoptosis through Activation of NF-κB Pathway in Rheumatoid Arthritis Synovial Cells , 2015, Mediators of inflammation.

[79]  Hai-Ming Wu,et al.  4-Hydroxynonenal promotes growth and angiogenesis of breast cancer cells through HIF-1α stabilization. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[80]  L. Milković,et al.  Oxidative stress and antioxidants in carcinogenesis and integrative therapy of cancer. , 2014, Current pharmaceutical design.

[81]  N. Žarković,et al.  Transcriptional and antioxidative responses to endogenous polyunsaturated fatty acid accumulation in yeast , 2014, Molecular and Cellular Biochemistry.

[82]  J. Fior Salamander Regeneration as a Model for Developing Novel Regenerative and Anticancer Therapies , 2014, Journal of Cancer.

[83]  Antonio Ayala,et al.  Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal , 2014, Oxidative medicine and cellular longevity.

[84]  D. Aizenbud,et al.  The effects of acetaldehyde and acrolein on muscle catabolism in C2 myotubes. , 2013, Free radical biology & medicine.

[85]  L. Butterfield,et al.  Melanoma‐associated leukoderma – immunology in black and white? , 2013, Pigment cell & melanoma research.

[86]  Robert V Farese,et al.  Cellular fatty acid metabolism and cancer. , 2013, Cell metabolism.

[87]  F. Gentile,et al.  Interaction of aldehydes derived from lipid peroxidation and membrane proteins , 2013, Front. Physiol..

[88]  L. Milković,et al.  The effects of angiotensin II and the oxidative stress mediator 4-hydroxynonenal on human osteoblast-like cell growth: possible relevance to otosclerosis. , 2013, Free radical biology & medicine.

[89]  C. Spickett The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis☆ , 2013, Redox biology.

[90]  N. Žarković,et al.  Elevated neutrophil elastase and acrolein‐protein adducts are associated with W256 regression , 2012, Clinical and experimental immunology.

[91]  G. Barrera Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy , 2012, ISRN oncology.

[92]  M. Sade-Feldman,et al.  New insights into chronic inflammation-induced immunosuppression. , 2012, Seminars in cancer biology.

[93]  W. Wahli,et al.  PPARs at the crossroads of lipid signaling and inflammation , 2012, Trends in Endocrinology & Metabolism.

[94]  M. Hilvo,et al.  Regulation of lipid metabolism in breast cancer provides diagnostic and therapeutic opportunities , 2012 .

[95]  G. Ansari,et al.  Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: dose- and time-response studies in female MRL+/+ mice. , 2012, Toxicology.

[96]  B. Tudek,et al.  Damage of DNA and proteins by major lipid peroxidation products in genome stability , 2012, Free radical research.

[97]  A. Brú,et al.  Polymorphonuclear neutrophils and cancer: Intense and sustained neutrophilia as a treatment against solid tumors , 2011, Medicinal research reviews.

[98]  S. Ferrini,et al.  Exocytosis of azurophil and arginase 1‐containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation , 2011, Journal of leukocyte biology.

[99]  Rafael Sirera,et al.  The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[100]  M. Grce,et al.  Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[101]  N. Žarković,et al.  Granulocytes as effective anticancer agent in experimental solid tumor models. , 2010, Immunobiology.

[102]  T. Oberley,et al.  Extracellular/microenvironmental redox state. , 2010, Antioxidants & redox signaling.

[103]  M. Jaganjac,et al.  Possible involvement of granulocyte oxidative burst in Nrf2 signaling in cancer. , 2010, The Indian journal of medical research.

[104]  N. Žarković,et al.  HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats , 2010, Free radical research.

[105]  N. Žarković,et al.  Distribution of 4-hydroxynonenal-protein conjugates as a marker of lipid peroxidation and parameter of malignancy in astrocytic and ependymal tumors of the brain. , 2009, Tumori.

[106]  E. Arısan,et al.  Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation. , 2009, Carcinogenesis.

[107]  G. Poli,et al.  4‐Hydroxynonenal: A membrane lipid oxidation product of medicinal interest , 2008, Medicinal research reviews.

[108]  N. Žarković,et al.  Adaptation to oxidative stress induced by polyunsaturated fatty acids in yeast. , 2008, Biochimica et biophysica acta.

[109]  N. Žarković,et al.  The involvement of granulocytes in spontaneous regression of Walker 256 carcinoma. , 2008, Cancer letters.

[110]  I. Rusyn,et al.  Predictive Power of Biomarkers of Oxidative Stress and Inflammation in Patients with Hepatitis C Virus-Associated Hepatocellular Carcinoma , 2007, Annals of Surgical Oncology.

[111]  N. Žarković,et al.  Oxidative burst of neutrophils against melanoma B16-F10. , 2007, Cancer letters.

[112]  N. Žarković,et al.  Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells , 2007, Redox report : communications in free radical research.

[113]  J. Li,et al.  Glutathione S-transferases as antioxidant enzymes: small cell lung cancer (H69) cells transfected with hGSTA1 resist doxorubicin-induced apoptosis. , 2006, Archives of biochemistry and biophysics.

[114]  N. Žarković,et al.  c-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa. , 2006, Free radical biology & medicine.

[115]  A. M. Hicks,et al.  Transferable anticancer innate immunity in spontaneous regression/complete resistance mice , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[116]  N. Žarković,et al.  Saccharomyces cerevisiae strain expressing a plant fatty acid desaturase produces polyunsaturated fatty acids and is susceptible to oxidative stress induced by lipid peroxidation. , 2006, Free radical biology & medicine.

[117]  N. Žarković,et al.  Enzyme-linked immunosorbent assay for 4-hydroxynonenal–histidine conjugates , 2006, Free radical research.

[118]  Federica Briatore,et al.  4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line. , 2005, Free radical biology & medicine.

[119]  G. Bauer,et al.  Proapoptotic and redox state-related signaling of reactive oxygen species generated by transformed fibroblasts , 2002, Oncogene.

[120]  N. Žarković,et al.  Associated changes of lipid peroxidation and transforming growth factor β1 levels in human colon cancer during tumour progression , 2002, Gut.

[121]  Federica Briatore,et al.  Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation. , 2002, Free radical biology & medicine.

[122]  N. Žarković,et al.  The carcinostatic and proapoptotic potential of 4-hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins. , 2001, Anticancer research.

[123]  C. Harris,et al.  Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[124]  F. Bazzoni,et al.  The neutrophil as a cellular source of chemokines , 2000, Immunological reviews.

[125]  S. Toyokuni,et al.  Localization of hydroxynonenal protein adducts in normal human kidney and selected human kidney cancers. , 1999, Free radical biology & medicine.

[126]  U. Das Essential fatty acids, lipid peroxidation and apoptosis. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.

[127]  S. Brüsselbach,et al.  Inhibition of D1, D2, and A-cyclin expression in HL-60 cells by the lipid peroxydation product 4-hydroxynonenal. , 1999, Free radical biology & medicine.

[128]  N. Žarković,et al.  Treatment of the budding yeast Saccharomyces cerevisiae with the lipid peroxidation product 4-HNE provokes a temporary cell cycle arrest in G1 phase. , 1998, Free radical biology & medicine.

[129]  G. Bauer,et al.  Reactive oxygen species act at both TGF-beta-dependent and -independent steps during induction of apoptosis of transformed cells by normal cells. , 1996, Experimental cell research.

[130]  J. Lehmann,et al.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.

[131]  V. Fazio,et al.  Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line. , 1994, Biochemical and biophysical research communications.

[132]  N. Žarković,et al.  Stimulation of HeLa cell growth by physiological concentrations of 4‐hydroxynonenal , 1993, Cell biochemistry and function.

[133]  V. Fazio,et al.  Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation. , 1991, Experimental cell research.

[134]  N. Žarković,et al.  [Inhibition of growth of B16 melanoma caused by liver regeneration]. , 1990, Lijecnicki vjesnik.

[135]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[136]  N. Žarković,et al.  Mitochondrial control of apoptosis through modulation of cardiolipin oxidation in hepatocellular carcinoma: A novel link between oxidative stress and cancer , 2017, Free radical biology & medicine.

[137]  Y. Fouad,et al.  Revisiting the hallmarks of cancer. , 2017, American journal of cancer research.

[138]  N. Žarković,et al.  Pathophysiology of neutrophil-mediated extracellular redox reactions. , 2016, Frontiers in bioscience.

[139]  V. Dhawan Reactive Oxygen and Nitrogen Species: General Considerations , 2014 .

[140]  N. Hay,et al.  Molecular Pathways Molecular Pathways : Reactive Oxygen Species Homeostasis in Cancer Cells and Implications for Cancer Therapy , 2013 .

[141]  Michael J Morgan,et al.  Crosstalk of reactive oxygen species and NF-κB signaling , 2011, Cell Research.

[142]  Karolj Skala,et al.  Specific thermographic changes during Walker 256 carcinoma development: differential infrared imaging of tumour, inflammation and haematoma. , 2009, Cancer detection and prevention.

[143]  N. Žarković,et al.  Immunohistochemical appearance of HNE‐protein conjugates in human astrocytomas , 2005, BioFactors.

[144]  N. Žarković,et al.  A new method for detection of HNE-histidine conjugates in rat inflammatory cells , 2005 .

[145]  N. Žarković,et al.  Oxidative burst and anticancer activities of rat neutrophils , 2005, BioFactors.

[146]  N. Žarković,et al.  The influence of 4‐hydroxy‐2‐nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells , 2005, BioFactors.

[147]  N. Žarković,et al.  Differential influence of the lipid peroxidation product 4-hydroxynonenal on the growth of human lymphatic leukaemia cells and human periopherial blood lymphocytes. , 2002, Anticancer research.

[148]  G. Bauer,et al.  Signaling and proapoptotic functions of transformed cell-derived reactive oxygen species. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[149]  A. Markowska,et al.  [Spontaneous tumor regression]. , 1998, Ginekologia polska.

[150]  G. Bauer Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis. , 1996, Histology and histopathology.

[151]  V. Fazio,et al.  Effect of 4-Hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells. , 1996, Free radical biology & medicine.

[152]  N. Žarković,et al.  Inhibition of melanoma B16-F10 growth by lipid peroxidation product 4-hydroxynonenal. , 1995, Cancer biotherapy.

[153]  H. Stam,et al.  The spontaneous regression of cancer. A review of cases from 1900 to 1987. , 1990, Acta oncologica.

[154]  Edward F. Lewison,et al.  Conference on Spontaneous Regression of Cancer, held at the Johns Hopkins Medical Institutions, Baltimore, Maryland, May 9 and 10, 1974 , 1976 .

[155]  W. Cole,et al.  Spontaneous regression of malignant disease. , 1959, Journal of the American Medical Association.

[156]  S. Rose,et al.  Transformation of renal tumors of frogs to normal tissues in regenerating limbs of salamanders. , 1948, Science.

[157]  Mong-Hong Lee,et al.  Cancer Metabolism: Major Remodeling of Cellular Energy Production and Metabolic Pathways in Tumors Cancer Metabolic Reprogramming: Importance, Main Features, and Potentials for Precise Targeted Anti-cancer Therapies , 2022 .

[158]  S. Vasanthan,et al.  Journal of Medical Case Reports Spontaneous Regression of Metastatic Renal Cell Carcinoma: Case Report Case Presentation , 2022 .